Group A Meningococcal Polysaccharide Vaccine - 搜索结果

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

必思諾b型腦膜炎雙球菌疫苗

荷商葛蘭素史克藥廠股份有限公司台灣分公司台北市中正區忠孝西路一段66號23-24樓 (86927438) - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953);;recombinant neisseria meningitidis group b nada protein (rp961c);;recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741);;outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 - 懸浮注射液 - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953) (8008004010) mcg; recombinant neisseria meningitidis group b nada protein (rp961c) (8008004020) mcg; recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741) (8008004030) mcg; outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 (8008004040) mcg - meningococcus b, multicomponent vaccine - 適用於2個月以上兒童及成人之主動免疫接種，以預防b型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

腦寧安腦膜炎雙球菌四價接合型疫苗

荷商葛蘭素史克藥廠股份有限公司台灣分公司臺北市中正區忠孝西路一段66號23、24樓 (86927438) - meningococcal group a oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein;;meningococcal group c oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein;;meningococcal group w-135 oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein;;meningococcal group y oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein - 注射用凍晶粉末與注射用液劑 - meningococcal group a oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein (8008000150) meningococcal group a oligosaccharide......10 micrograms conjugated to corynebacterium diphtheriae crm197 protein......16.7 to 33.3 micrograms; meningococcal group c oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein (8008000152) meningococcal group c oligosaccharide......5 micrograms conjugated to corynebacterium diphtheriae crm197 protein......7.1 to 12.5 micrograms; meningococcal group w-135 oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein (8008000154) meningococcal group w-135 oligosaccharide......5 micrograms conjugated to corynebacterium diphtheriae crm197 protein......3.3 to 8.3 micrograms; meningococcal group y oligosaccharide conjugated to corynebacterium diphtheriae crm197 protein (8008000156) meningococcal group y oligosaccharide......5 micrograms conjugated to corynebacterium diphtheriae crm197 protein......5.6 to 10.0 micrograms - meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated - menveo 可用於幼童(2 歲及以上)、青少年與成人(≦55 歲)的主動免疫接種，以預防腦膜炎雙球菌(neisseria meningitidis)血清型a、c、w-135與y 所引起的侵入性疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

哈多星六合一疫苗

賽諾菲股份有限公司台北市信義區松仁路3號7樓 (97168356) - diphtheria toxoid;;tetanus toxoid;;pertussis bordetella;;pertussis toxoid;;filamentous haemagglutinin;;inactivated poliovirus vaccine type i;;inactivated poliovirus vaccine type ii;;inactivated poliovirus vaccine type iii;;hepatitis b, antigen, surface;;polysaccharide of haemophilus influenzae type b;;conjugated to the tetanus protein - 懸浮注射液 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) diphtheria toxoid….……30lf (≧20iu)iu; tetanus toxoid (8008000200) tetanus toxoid..…………10lf (≧40iu)iu; conjugated to the tetanus protein (8008000230) 22-36μg; pertussis bordetella (8012000110) bordetella pertussis antigens; inactivated poliovirus vaccine type i (8012002201) (mahoney)du; inactivated poliovirus vaccine type ii (8012002202) (mef-1)du; inactivated poliovirus vaccine type iii (8012002203) (saukett)du; polysaccharide of haemophilus influenzae type b (8012020000) (polyribosylribitol phosphate)ug; hepatitis b, antigen, surface (8081211000) ug; filamentous haemagglutinin (9200050300) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - 適用於出生6週以上之嬰兒及幼兒的基礎免疫接種和追加接種，以預防白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌(hib)所導致的侵襲性疾病。